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Introduction
Abstract: In this study, we evaluated how different procedures of calcium phosphate synthesis and its incorporation in collagen:chitosan 
scaffolds could affect their structural and thermal properties, aiming the obtention of homogeneous scaffolds which can act as drug delivery 
vehicles in bone tissue engineering. Therefore, three different scaffold preparation procedures were developed, changing the order of addition 
of the components: in CC-CNPM1 and CC-CNPM2, calcium phosphate synthesis was performed in situ in the chitosan gel (1%, w/w) followed 
by mixture with collagen (1%, w/w), with changes in the reagents used for calcium phosphate formation; in CC-CNPM3 procedure, calcium 
phosphate was synthesized ex situ and then incorporated into the collagen gel, in which chitosan in powder was mixed. In all procedures, 
5% (in dry mass) of ciprofloxacin was incorporated. FTIR analysis confirmed the presence of calcium phosphate in all scaffolds. DSC curves 
showed that collagen denaturation temperature (Td) increased with calcium incorporation. SEM photomicrographs of scaffolds cross-section 
revealed porous scaffolds with calcium phosphate grains internally distributed in the polymeric matrix. XRD diffractograms indicated that the 
calcium phosphates obtained are hydroxyapatite. The pore size distribution was more homogeneous for CC-CNPM3, which also stood out 
for its smaller porosity and lower absorption in PBS. These results indicate that the in situ or ex situ phosphate incorporation in the scaffolds 
had a great influence on its structural properties, which also had consequences for ciprofloxacin release. CC-CNPM3 released a smaller 
amount of antibiotic (30%), but its release profile was better described by all the tested models. 
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Introduction
Tissue engineering is an interdisciplinary field of sciences which 
uses principles and methods from engineering, biology, chemistry and 
physics in order to replace, keep or increase biological functions of tis-
sues or damaged organs.1 Tissue engineering studies aim to eliminate 
some of the main disadvantages of conventional clinical treatments, such 
as high cost, excessive recovery time and possibility of infections. 
One of the major areas of tissue engineering is the bone tissue engi-
neering. Bones consist of inorganic compounds such as calcium hydroxy 
phosphate (Ca5(PO4)3OH), also known as hydroxyapatite (HA), calcium 
carbonate, as well as small quantities of bicarbonate, citrate, magne-
sium, potassium and traces of other metals. All this inorganic composi-
tion represents 65% of bone. 25% is composed of organic compounds 
as collagen type I, proteoglycans, carbohydrates, besides other pro-
teins. The 10% left correspond to water.2 
Bone regeneration involves the selection and migration of osteopro-
genitors cells, followed by their proliferation, differentiation, matrix for-
mation and bone remodulation.3 Due to the many in vitro steps involved 
in the process, numerous variables can affect it, such as pH, fluid flow, 
mechanic and biochemical stimuli, culture medium, temperature, im-
munologic and inflammatory process, enzymes, as well as number, or-
igin, mobility and activity from cells.3,4 For this reason, the latest studies 
in tissue engineering focus on the development of biomaterial-based 
scaffolds capable of absorbing and releasing bioactive compounds and 
drugs, besides accelerating the healing response and promoting proper 
tissue formation.4 
Scaffolds have been widely used in bone regeneration as a support 
throughout the recovery process, mimicking the porous architecture of 
the bone.5 Besides the support, scaffolds must promote tissue grow-
ing, nutrients transport, oxygen diffusion and integration with the host 
bone, presenting a good biocompatibility with the osteoblasts. During 
the structural development of the scaffolds, mechanical and biolog-
ical properties as porosity, pores size, water absorption, mechanical 
strength and pores shape need to be evaluated and controlled, as they 
will dictate the ability of the developed material to be applied as an im-
plant or bone substitute.6,7 
Among the main materials used in the development of scaffolds are 
natural polymers such as chitosan and collagen, as well as ceramics and 
minerals needed to mimic the structure and composition of a natural 
bone.8,9 Calcium phosphates are one of the most widely used, as they 
have properties such as nontoxicity, noninflammatory response, and the 
ability to bind directly to the host bone.10 Moreover, calcium phosphates 
as hydroxyapatite can be used in implants and as bone substitutes due 
its excellent biocompatibility, bioactivity, affinity to biopolymers and os-
teoconductivity.11,12 These phosphates can be prepared in many forms, 
as a dense ceramic, in powder, in particles of micrometric or even nano-
metric size, according to their applications.13 HA as nanometric particles 
has a similarity with the morphology of mineral grains found in bone. 
Nanometric particles have a greater surface area in relation to volume, 
which causes an increase in proteins absorption and cellular adhesion in 
the scaffolds and improves biological and mechanical properties.14 
Regarding to the natural polymers, the applicability of collagen in 
tissue engineering brings advantages as its excellent biocompatibility, 
biodegradability and cellular adhesion properties.9 In addition, as al-
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ready mentioned, type I collagen is the most abundant protein in the 
extracellular matrix of bone, which justifies its widespread use in bone 
tissue engineering. Many studies have already involved the development 
of scaffolds, composites and other types of collagen-based materials, 
associating them with calcium phosphates for bone regeneration: Kee-
ney et al. (2010),15 developed collagen and calcium phosphate scaffolds 
as vectors of plasmid DNA transfer; Inzana et al. (2014),16 developed a 
3D printing study of scaffolds based on collagen and calcium phosphate, 
characterizing them in relation to their cytocompatibility and cell viability.
However, this field still has limitations related to collagen-scaf-
folds faster degradation and weaker mechanical properties than natural 
bone.17 To minimize these disadvantages, some effort has been con-
centrated in the development of collagen chemically reticulated and/or 
combined with natural and synthetic polymers. In this sense, the addition 
of a polymer such as chitosan to the scaffold is an alternative due its bio-
compatibility, biodegradability, plasticity, adhesiveness and osteocon-
ductive properties.13 For an example, Zugravu et al. (2012)5 developed 
scaffolds based on chitosan/collagen/calcium phosphate microparticles, 
evaluating the advantages brought by the association of collagen with 
chitosan over in vitro compatibility and material biodegradability. 
Besides obtaining the scaffolds, one of the biggest problems in sur-
gical interventions is related to the possibility of infections, what takes to 
the systemic use of antibiotics. Antibiotics administration involves toxicity 
and a high incidence of antibiotic resistance.18,19 To avoid these problems 
a rational use of these drugs is required, avoiding excess or yet the local 
use instead of systemic treatments. So, a release system that controls 
the antibiotic rate and keeps its therapeutic concentration during a long 
period is an advantage over the conventional methods. 
To the best of our knowledge, despite numerous reports in the lit-
erature on the development of scaffolds and other types of collagen, 
chitosan and calcium phosphate-based materials, there is no study 
evaluating different procedures for the incorporation of calcium phos-
phate salts in the polymer matrix. The order-of-addition of component 
materials should have effects on the structural properties such as po-
rosity and pore size, thermal properties such as collagen denaturation 
temperature and the in vitro antibiotic release, all of them evaluated in 




All solvents and reagents were of analytical grade and used without 
further purification. The bovine tendon used for collagen extraction was 
obtained at Casa de Carnes Santa Paula, São Carlos – SP. Doryteuthis 
spp. squid pens were obtained at Miami Comércio e Exportação de Pes-




To obtain collagen, tendon bovine was treated in an alkaline solution 
containing salts (chlorides and sulfates of Na+, K+ and Ca2+) for 72 h at 
25ºC, according to the procedure described by Horn et al. (2009).20 The 
excess salts were removed by washing in solutions of boric acid (H3BO3) 
and deionized water, followed by washings in EDTA solution and deion-
ized water. Collagen was extracted in pH 3.5 acetic acid (HAc) solution. 
Collagen gel concentration of 0.98 ± 0.23% was determined by lyo-
philization.
Chitosan obtention
Chitosan was prepared from squid pens (Doryteuthis spp.) follow-
ing the procedure of deproteinization and deacetylation adapted from 
Horn et al. (2009).20 The reaction yield was 27.8%, which agrees with a 
previous study.21 For chitosan characterization, its acetylation degree 
(6.7%)22 was determined in a previous study by proton nuclear magnetic 
resonance spectroscopy (1H NMR), according to the method developed 
and validated by Lavertu et al. (2003).23 Chitosan molecular weight (327 
kDa)22 was also previously determined by capillary viscosimetry proce-
dure, according to Rinaudo (2006).24 1% (w/w) chitosan gel was obtained 
in a 1% (w/w) HAc solution, under stirring for 24 h.
Preparation of collagen:chitosan:calcium phosphate scaf-
folds
In this study, three different procedures for calcium phosphate syn-
thesis and incorporation in collagen and chitosan scaffolds were devel-
oped, by changing the reagents used, the order of addition of scaffold 
components and the in situ or ex situ synthesis of phosphate. In all of 
them, the collagen:chitosan ratio was kept in 1:1 and the amount of cal-
cium phosphate incorporated was the same (35% in relation to the total 
dry mass of the polymers), being controlled by the molarity and the vol-
ume of reagents added in the system. The three procedures developed 
are described as following:
Procedure 1 (CC-CNPM1)
CaCl2 and (NH4)2HPO4 at the concentrations of 0.2 mol L
-1 and 0.12 
mol L-1, respectively, were added in the 1% (w/w) chitosan gel, followed 
by stirring for 24 h. The pH was raised to 9.0 with 1.0 mol L-1 NH4OH 
and the stirring kept for more two days. Excess salts of material were 
removed with water and the chitosan containing the calcium phosphate 
synthesized was solubilized in HAc solution pH 3.5.
Procedure 2 (CC-CNPM2)
A 0.3 mol L-1 solution of H3PO4 was added in the 1% (w/w) chitosan 
gel (in HAc) under constant stirring. Then, a 0.5 mol L-1 Ca(OH)2 ethanolic 
solution was slowly dropped in the mixture, keeping the pH 9.0 for two 
days. Excess salts of material were removed with water and the chitosan 
containing the synthesized calcium phosphate was solubilized in HAc 
solution pH 3.5.
In the two procedures described above, the material obtained in situ 
synthesis of calcium phosphate in chitosan was added to the collagen 
gel (1% w/w, in HAc pH 3.5) and kept under stirring for two days, in order 
to obtain homogeneous mixtures. The air was removed from the sam-
ples, which were placed in Teflon® molds, frozen and freeze-dried. The 
scaffolds obtained were washed in phosphate buffer saline (PBS) pH 7.4 
and in deionized water, frozen and lyophilized. 
Procedure 3 (CC-CNPM3)
Nano-calcium phosphate (NCP) was synthetized according to 
the procedure described by Gopi et al. (2015).10 In brief, 0.05 mol
 L-1 CaCl2.2H2O was added to a 0.15% pectin solution, under stirring for 1 
h. 0.03 mol L-1 (NH4)2HPO4 was dropped into the mixture, under vigorous 
stirring for 3 h. The pH was adjusted to 9.0 with 1.0 mol L-1 NH4OH, and 
after 24 h the white precipitate was dried at 80ºC, washed with deionized 
water and ethanol. Finally, calcination eliminated the pectin matrix, 
ensuring that the powder obtained was only calcium phosphate.  
The synthesized calcium phosphate was added to the 1% (w/w) 
collagen gel (in HAc pH 3.5), keeping the same ratio of the calcium 
phosphates incorporated on scaffolds of Procedures 1 and 2 (35%). The 
mixture was kept under stirring for 60 min. Chitosan powder was then 
added to the mixture, kept under stirring for another 24 h. Thus, this 
procedure changed not only calcium phosphate ex situ synthesis, but 
also the order of salt addition, being initially added to collagen for later 
incorporation of chitosan powder (and not chitosan gel, as in the other 
procedures).
The resultant mixture was placed in Teflon® molds, frozen and 
freeze-dried. The scaffolds were washed in PBS pH 7.4 and in deionized 
water, frozen and lyophilized.
Ciprofloxacin incorporation
Once the three procedures for obtaining the scaffolds were devel-
oped, the antibiotic ciprofloxacin was incorporated into the mixtures. To 
this end, about 15 g of the mixtures were separated before being frozen 
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and lyophilized, and to this amount of material 5% (w/w, relative to the 
dry mass of the polymers) of ciprofloxacin powder, corresponding to 7.5 
mg, was added. Thus, the final antibiotic concentration in relation to the 
collagen:chitosan:calcium phosphate mixture was 0.5 mg g-1. These 
new mixtures were homogenized by stirring, placed in Teflon® molds, 
frozen and lyophilized. Scaffolds were neutralized in ammonium vapor 
for 24 h and aerated under constant air flow for 72 h, being denominated 
CC-CNPM1-C, CC-CNPM2-C and CC-CNPM3-C. 
Fourier transform infrared spectroscopy (FTIR)
CC-CNPM1, CC-CNPM2 and CC-CNPM3 samples were diluted in 
HAc pH 3.5 (in the ratio of 1:3), placed in Teflon® molds and dried under 
air flow, in order to form films by the casting method. The spectra were 
obtained in a FTIR Shimadzu IR Affinity – 1 at a 400 a 4000 cm-1 interval 
with 4 cm-1 of resolution.
Thermal stability
Denaturation temperature of collagen present in the scaffolds was 
obtained by differential scanning calorimeter (DSC) in N2 atmosphere 
using a DSC-2010 (TA Instruments). A sample of 20 mg was used, and 
the heating rate was 10ºC min-1, with a temperature range from 5 to 
120ºC. For the quantification of residue in the scaffolds, thermogravi-
metric curves (TG) were obtained with a TGA-Q50 (TA Instruments). A 
sample of 10 mg was used, with a heating rate of 10ºC min-1 and the 
temperature range was from 25ºC to 800ºC, under synthetic air atmo-
sphere. 
Scanning electron microscopy (SEM)
The scaffolds morphology was observed using a ZEISS LEO 440 
(Cambridge, England) equipment, with an OXFORD detector (model 
7060) and an electron beam of 20 kV. Before the analysis, the scaffolds 
were affixed in stubs with conductive carbon tape and covered with a 6 
nm gold layer. The software UTHSCSA Image Tool was used to measure 
the scaffolds pores. For each one, 20 measures were performed. 
X-rays diffraction (XRD)
X-rays diffraction provides a better understanding of the size and 
nature of synthesized calcium phosphate grains, checking for the pres-
ence of crystalline structures in the scaffolds developed. The analysis 
was performed using monochromatic radiation of CuK, 1,5406 Å, 50 kV, 
scanning speed of 2o min-1 and 2θ between 5 and 80o. Using the diffrac-
togram and the Scherrer’s equation (1),25 the crystal size was calculated:
 (1)
In this equation, K is a constant related to the grain size, being its 
value close to the unitary; λ is the x-ray radiation wavelength (nm); β 
is the widening of the diffraction peak 002, measured at half the maxi-
mum peak intensity, in radians, and θ is the Bragg diffraction angle, in 
degrees.
Porosity
Scaffold porosity was determined in quintuplicate, according to the 
procedure described by Nwe et al. (2009).6 Scaffolds were soaked over-
night in water; tissue papers were dried overnight, and their weights 
were measured. The wet scaffolds had their diameter and thickness 
measured, so their volume could be calculated. They were placed on the 
top of the tissue papers and centrifuged at 4,500 rpm for 5 min. The 
mass of the wet tissue papers was measured, and then the volume of 
the water absorbed by the scaffold was determined. The porosity was 
calculated by the relation between this volume (V2) and the volume of 




The study of scaffolds absorption in PBS pH 7.4 was performed in 
quintuplicate. The dried scaffolds were weighted, placed in PBS buffer 
and reweighted at specific times. At the end, the percentage of buffer 
absorbed by each scaffold was calculated using Equation (3). 
  
(3)
Where mw is the mass of the wetted scaffold, in specific times, and 
md is the initial mass of dried scaffold. 
Ciprofloxacin release
The ciprofloxacin release study was made in quintuplicate, by the 
immersion of scaffolds in 100 mL of PBS pH 7.4, under 100 rpm of stir-
ring and at 37ºC. In specific time intervals, aliquots of 1.0 mL were col-
lected, being replaced by 1.0 mL of PBS. Absorbance was read at 271 
nm, using a UV spectrophotometer (model HITACHI U-3000). 
Statistical analysis
The Shapiro-Wilk test was used to verify data distribution. Pore sizes 
and porosity results were examined using analysis of variance (ANOVA), 
followed by Tukey’s test. Significance level was set at 5 % in all cases.
Results And Discussion
All scaffolds obtained were porous, homogeneous and white in 
color, without visible calcium phosphate precipitates. The presence of 
ciprofloxacin antibiotic did not bring visible changes in the appearance 
of scaffolds.
Fourier transform infrared spectroscopy (FTIR)
FTIR analysis aims to verify the presence of calcium phosphate char-
acteristics bands in the samples, the first of a series of analysis that allow 
the confirmation of its incorporation in the scaffolds by the tested pro-
cedures. In addition, it can also endorse the presence of typical bands of 
the polymers used as the scaffolds matrix (collagen and chitosan). FTIR 
spectra of the samples (CC-CNPM1, CC-CNPM2 and CC-CNPM3) and 
of the calcium phosphate used in Procedure 3 are shown in Fig. 1. 
The spectrum of calcium phosphate confirmed the presence of sev-
eral characteristics bands: the band at 560 cm-1 refers to the deformation 
of P-O bond in the phosphate group (PO4
2-), while the band at 1041 cm-1 
is related to P-O stretching.26 The same phosphate bands (560 and 1041 
cm-1) were present in the scaffolds spectra, which also presented large 
bands at 3300 cm-1 referring to the O-H deformation, and characteristics 
bands of the polymers (collagen and chitosan), as observed at 1630 cm-
1, 1540 cm-1 and 1230 cm-1 (amides I, II and III, respectively).27 At 1410 
and 1450 cm-1 can also be observed bands referring to the carbonate 
group (CO3
2-), usually present in calcium deficient hydroxyapatites as a 
form of charge compensation.28 All spectra were similar to each other, 
with no emphasis on any bands that emerged or differentiated between 
them.
𝐿𝐿002 =  
𝐾𝐾 𝜆𝜆
𝛽𝛽 cos 𝜃𝜃 
𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 (%) = (𝑉𝑉2𝑉𝑉1) 𝑥𝑥 100 
% 𝑃𝑃𝑃𝑃𝑃𝑃 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 = (𝑚𝑚𝑚𝑚 − 𝑚𝑚𝑎𝑎𝑚𝑚𝑎𝑎 ) 𝑥𝑥 100 
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Thermal stability 
The denaturation temperature (Td) obtained by DSC are presented in 
Table 1. The analysis was also performed for collagen used in the prepa-
ration of scaffolds, and its Td was determined to be 44.8°C. According 
to Table 1, it is possible to observe an increase in the values in relation to 
this collagen, which indicates that the calcium phosphate incorporation 
increased collagen thermal stability, requiring more than 63°C to dena-
ture its triple helix.29 
Thermogravimetric curves for CC-CNPM1, CC-CNPM2 and 
CC-CNPM3 revealed similar profiles, as shown in Fig. 2. Three stages 
of weight loss can be observed: from 25 to 200°C, the loss of struc-
tural water takes place; the second stage, from 200 to 400°C, is related 
to the thermal degradation of the collagen structure; finally, the third 
step refers to the components decomposition and carbonization (400-
700ºC).29 Slight differences can be observed in each one of the steps. In 
general, it is observed that the CC-CNPM1 presented the lowest mass 
loss values in these three steps. 
Furthermore, in all cases it can be observed residues at 700°C re-
lated to inorganic components of the scaffolds, especially the calcium 
phosphate which does not decompose in this temperature range.30 As 
shown in Fig. 2, calcium phosphate shows a slight loss of water at the 
beginning of its curve and remains stable without decomposition over 
almost the entire working temperature range. Comparing the residu-
al values found for the scaffolds, it can be said that CC-CNPM1 stood 
out with the highest calcium phosphate content, almost the double of 
the scaffolds obtained by the other procedures. Thus, it is believed that 
Procedure 1 generated the largest amount of calcium phosphate in its 
synthesis in situ. Thermogravimetry may have been a first indication of 
the influence of the different adopted procedures on the properties of 
the obtained scaffolds.
Figure 1 -  FTIR spectra of CC-CNPM1, CC-CNPM2, CC-CNPM3 and of the calcium phosphate used in Procedure 3.
Figure 2 - Thermogravimetric curves for CC-CNPM1, CC-CNPM2, CC-NPM3 and synthesized calcium phosphate.
 
Table 1 - Thermal parameters and residue content at 700°C of CC-CNPM1, CC-CNPPM2 and CC-CNPM3 scaffolds.
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Scanning electron microscopy (SEM) 
The photomicrographs obtained by SEM are shown in Fig. 3. The 
scaffolds were porous, with calcium phosphate grains internally distrib-
uted throughout the polymer matrix and no larger than 300 nm. However, 
differences can be observed regarding the quantity and size of scaffold 
pores, as well as regarding the morphology of the grains and their quantity.
From Fig. 3A, 3C and 3E, all with the same magnification (25,000x), 
there is a distinct difference with respect to the morphology of the scaf-
folds: although CC-CNPM3 presents itself as a more compact scaffold and 
its pores are more homogeneous and better distributed, the same does 
not occur in CC-CNPM2, in which no well-defined pores are observed. 
Regarding to calcium phosphate (Fig. 3B, 3D and 3F), the formed 
grains are clearly different from each other. In CC-CNPM1, their nee-
dle-like shape resembles CC-CNPM3 grains, but in the latter case they 
are smaller and better distributed along the scaffold cross section. Li et 
al. (2010)31 reported obtaining needle-shaped apatite formed on the 
chitosan surface after a mineralization process by immersion in saline 
solutions. However, the grains obtained by them were about 7 times 
larger than the calcium phosphates formed in CC-CNPM1. On the oth-
er hand, the calcium phosphate grains in CC-CNPM2 are spherical in 
shape, aggregated and poorly distributed in the scaffold. The same 
spherical shape of calcium phosphates can be observed in the work of 
Zhao et al. (2008),32 who mineralized scaffolds based on collagen and 
chitosan, obtaining calcium phosphates of different shapes and sizes, 
according to the calcium ion concentration.
ImageJ software was used to measure the size of scaffold pores us-
ing SEM photomicrographs with 500x of magnification. Table 2 shows 
the average surface and cross-sectional pore size of the scaffolds. In 
general, all samples presented at least 40% of their surface pores with 
sizes that varied within the same range, which were larger for CC-CN-
PM2 (between 30 and 40 µm) than for the other two cases (Fig. 4). 
CC-CNPM3 presented smaller surface and cross-sectional pores, 
with approximately the same size range (5 to 40 µm), unlike CC-CN-
PM1 in which the cross-sectional pores were almost twice the average 
pore size of the surface pores. On the other hand, CC-CNPM2 showed a 
more heterogeneous pore size distribution, both at surface (range 10 to 
65 µm) and cross sectional (range 10 to 55 µm). Thus, from the analysis 
of SEM images and of the surface and cross-sectional pores of the sam-
ples, it can be concluded that the ex situ calcium phosphate incorpo-
ration adopted in CC-CNPM3 was the procedure that resulted in more 
homogeneous scaffolds with better defined pores.
According to Karageorgiou & Kaplan (2005),33 pores with sizes 
around 100 µm are favorable for cell growth and nutrient transport. 
Although the scaffolds developed by the three procedures presented 
pore sizes smaller than 100 µm, studies involving in vitro evaluation of 
osteoblasts growth in collagen scaffolds with smaller pores have already 
been successfully conducted.34
Figure 3 - Photomicrographs by SEM of cross section of: (A) and (B) CC-CNPM1, (C) and (D) CC-CNPM2, (E) and (F) CC-CNPM3. Magnitude of 
1,000x (A), (C) and (E); 25,000x (B) and (F); 30,000x (D). 
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In the same column, values with the same superscript letter (a-b) were not significantly different (P > 0.05).
Table 2 - Pores sizes by SEM photomicrographs for CC-CNPM1, CC-CNPM2 and CC-CNPM3 scaffolds. 
Figure 4 - Histograms of pore size distribution for surface (S) and cross-sectional (CS) SEM images.
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feres with the crystallinity of the mineral content. Zugravu et al. (2012),5 
studied the effects of different collagen concentrations on the calcium 
phosphate crystallinity incorporated in composite microparticles. They 
reported that at a 25% collagen concentration, calcium phosphate peaks 
completely disappeared from the spectra. Furthermore, in the scaffold 
spectra two additional peaks can be observed, at 2θ=10° and 2θ=20°, 
referring to the chitosan hydrous and anhydrous peaks, respectively.35 
The grain size of HA synthesized in Procedure 3 was measured by the 
enlargement of diffraction peak 002, indicated in the spectrum. Scherrer 
equation’s (1) was used to calculate the grain size, and the value obtained 
was 21.4 nm, which confirms HA synthesis in nanometric dimensions.
X-rays diffraction (XRD)
X-rays diffraction analysis was performed to identify the crystalline 
phases present in the scaffolds developed, as well as in the calcium 
phosphate synthesized ex situ for Procedure 3 (Fig. 5). 
As can be seen in Fig. 5, the peaks at 2θ=32° characteristic of the 
(211) plane of hydroxyapatite35 appear in all diffractograms presented, 
with greater intensity and better resolution in the case of isolated calcium 
phosphate diffractogram. The well-marked peaks confirm that the cal-
cium phosphates obtained in the procedures developed is this study are 
believed to be hydroxyapatite.
In the scaffold spectra, the presence of collagen and chitosan inter-
Figure 5 - Representative XRD spectra of collagen/chitosan/calcium phosphate scaffolds compared to the calcium phosphate synthesized in Pro-
cedure 3.
Scaffolds porosity and absorption in PBS
Scaffolds porosity, in addition to pores size and morphology, is an 
essential factor to be studied when considering the application of these 
materials in bone regeneration, as it influences processes such as water 
absorption, PBS absorption, migration and cell growth. Table 3 shows 
the porosity values obtained for the developed scaffolds, as well as their 
relative absorption percentage in PBS pH 7.4.
It can be observed from the porosity values presented that, although 
there are no significant statistical differences between the procedures, 
the scaffolds obtained by Procedures 1 and 2 (in situ procedures) 
showed a tendency to be more porous than the scaffolds prepared by 
Procedure 3, in which phosphate incorporation was ex situ. 
PBS absorption study is critical to evaluate whether prepared scaf-
folds can be used as controlled drug delivery vehicles. Fig. 6 shows the 
mean absorption curves in PBS as a function of time for CC-CNPM1, 
CC-CNPM2 and CC-CNPM3 scaffolds.
The percentage of PBS absorbed, as well as the absorption profile, 
differ between the scaffolds. While CC-CNPM1 and CC-CNPM2 both 
stabilized in 1,500% or more and in approximately 1 min, CC-CNPM3 
stabilized their absorption in 1,100% after 10 min. The absorption results 
may be related to the scaffold porosity: as seen, CC-CNPM3 was the least 
porous scaffold among the three developed, and it was expected that its 
PBS absorption was also the lowest. Nevertheless, all prepared scaffolds 
absorbed large amounts of buffer over a short period of time, which is 
a promising result for their use as drug carriers and delivery systems.
PBS absorption and porosity results, when combined with scaffolds 
pore size distribution data, allow an important conclusion to be drawn as 
the direction of this study: the order of addition of scaffold components, 
as well as the way calcium phosphate is incorporated, have a greater 
influence on the porous structure of the final material than the simple 
reagents change evaluated in the in situ procedures developed. Thus, 
CC-CNPM3 scaffolds were the least porous and absorbed less PBS but 
presented a more homogeneous pore distribution and smaller surface 
and cross-sectional pores. CC-CNPM1 and CC-CNPM2, in turn, de-
spite having different pore size distributions, presented similar porosi-
ties and absorption profiles.
 
In the same column, values with the same superscript letter (a) were not significantly different (P > 0.05).
Table 3 - Porosity and PBS absorption for CC-CNPM1, CC-CNPM2 and CC-CNPM3. 
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Ciprofloxacin release
Fig. 7 shows the mean release profile of ciprofloxacin by the scaffolds. 
As expected, CC-CNPM3-C presented the most distinct profile, releas-
ing approximately 30% (0.4 mg) of their incorporated antibiotic after about 
2 h of assay. CC-CNPM1-C and CC-CNPM2-C released 40% (0.45 mg) 
and 63% (0.7 mg) of their ciprofloxacin, respectively, stabilizing these per-
centages after about 1 h of assay.
Although the release time was well balanced in all cases and stabilization 
occurred at acceptable time intervals, the maximum release percentages were 
relatively low. The reason for this may be related to the structure of ciprofloxacin: 
the antibiotic is a fluorquinolone, which can complex with calcium ions of 
phosphate present in scaffolds, making it difficult to release (Fig. 8).36,37 This 
fact also explains why CC-CNPM1-C released less antibiotic, despite having 
a PBS absorption profile similar to CC-CNPM2-C: its inorganic content was 
the highest, which implies a possible greater complexation between its HA 
incorporated therein and ciprofloxacin. 
Despite the released concentrations are low in relation to the total 
antibiotic incorporated, depending on the application to which the scaf-
fold is submitted (application site, type of injury) the amount of cipro-
floxacin released may still be enough or even higher than the required 
therapeutic concentration. According to the FDA, the recommended 
dose of ciprofloxacin to be consumed in a day is 250 to 1000 mg, but a 
concentration of 2 µg mL-1 is already enough to inhibit a huge range of 
microorganisms, as E. coli and S. aureus.38 Thus, all scaffolds developed 
in this study released larger amounts of ciprofloxacin in a much shorter 
time period than 24 h.
In order to better understand which drug release mechanisms were 
involved for each of the prepared scaffolds, different release models 
were tested, including: first order, second order, Hixson-Crowell, Bak-
er-Lonsdale, Korsmeyer-Peppas, Higuchi and Weilbull.39,40 Only the 
three last models showed satisfactory results for the samples developed 
in this study, and their equations and parameters are described in Table 4. 
Table 5 lists the main parameters obtained by modeling the cipro-
floxacin release curves for CC-CNPM1-C, CC-CNPM2-C and CC-CNPM3-C 
samples, according to the three models described above. As can be observed, 
CC-CNPM3-C was best fitted in all tested models, presenting the high-
est R values. The release curves of CC-CNPM1-C and CC-CNPM2-C 
were best adjusted by the Korsmeyer-Peppas model. This model is 
used in systems in which more than one process is involved in drug re-
lease: for samples with 0.5 < n <1.0, the drug transport mechanism is 
called anomalous or non-Fickian, and its release mechanisms can be 
by diffusion or by relaxation of polymeric chains.40 Otherwise, if n < 0.5 
the transport drug mechanism in denominated Quasi-Fickian diffusion, 
and its kinetics of diffusion is completely different from the non-Ficki-
an mechanism. In this case, it is believed that the polymer chains have 
more mobility, releasing a greater amount of drug by diffusion than the 
non-Fickian model would release.
According to Table 5, CC-CNPM1-C and CC-CNPM2-C showed 
Quasi-Fickian diffusion mechanisms, while CC-CNPM3-C presented a 
non-Fickian mechanism, releasing ciprofloxacin by diffusion and/or re-
laxation in the polymeric matrix. Different mechanisms of diffusion were 
really expected for this sample, since the profile of its release curve was 
very different from the others (Fig. 7), as well as its maximum amount of 
ciprofloxacin released. Thus, it can be said that although CC-CNPM3-C 
was the sample that released the least amount of antibiotic, its release 
was the most controlled of the three cases, and it would be chosen as the 
best release model for ciprofloxacin.
Figure 6 - PBS absorption profiles for CC-CNPM1, CC-CNPM2 and CC-CNPM3.
Figure 7 - Ciprofloxacin release profile of the scaffolds. Release conditions: 37°C, 100 rpm, absorbance reading at 271 nm.
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Figure 8 - Complexation between the ciprofloxacin and calcium ions from phosphates. 
Mt




Table 4 - Model equations used for fitting ciprofloxacin release data. 
Table 5 - Parameters obtained by modeling ciprofloxacin release curves for CC-CNPM1-C, CC-CNPM2-C and CC-CNPM3-C. 
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Conclusion
This study revealed an unprecedented study of the development of 
three distinct procedures for the synthesis and incorporation of calcium 
phosphates in collagen and chitosan-based polymeric systems, aiming 
to obtain homogeneous scaffolds that could act as controlled release 
vehicles of ciprofloxacin. The materials were structurally characterized, 
presenting internally distributed calcium phosphate grains and pores 
of different shapes and size distributions. Studies of scaffolds porosity, 
pore size and absorption in PBS were conducted, and all results pointed 
in the same direction: CC-CNPM1 and CC-CNPM2, in which calcium 
phosphate synthesis occurred in situ, presented porosities and absorp-
tion profiles in PBS quite different from CC-CNPM3, in which phosphate 
incorporation was by simple mixture, confirming that the order of addi-
tion of scaffold components actually interferes with their final structural 
properties. Finally, the release study of ciprofloxacin revealed by mod-
eling the data that CC-CNPM3-C stood out as the sample that released 
this antibiotic by both diffusion and relaxation of the polymeric matrix, 
although it released a smaller amount of the drug. It is expected that this 
study opens new possibilities of application of the developed materials, 
once some of the main important aspects for their application in the area 
of bone regeneration have been characterized.
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